H. D. de Koning

发表

Nodule management protocol of the NELSON randomised lung cancer screening trial.

D. Xu, H. Gietema, H. D. de Koning, 2006, Lung cancer.

H. D. de Koning, M. Oudkerk, R. Vliegenthart, 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

J. Habbema, H. D. de Koning, K. Nackaerts, 2007, International journal of cancer.

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy

H. D. de Koning, W. Mali, J. Groenewoud, 2004, British Journal of Cancer.

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

H. D. de Koning, J. Klijn, R. Tollenaar, 2004, The New England journal of medicine.

MISCAN: estimating lead‐time and over‐detection by simulation

H. D. de Koning, G. Draisma, H. D. de Koning, 2003, BJU international.

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

Harry J de Koning, Mieke Kriege, Carla Boetes, 2006, Cancer.

Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.

Harry J de Koning, Mathias Prokop, Rozemarijn Vliegenthart, 2008, European journal of radiology.

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.

P. V. van Diest, N. Karssemeijer, H. D. de Koning, 2019, The New England journal of medicine.

Screening and prostate-cancer mortality in a randomized European study.

B. G. Blijenberg, T. H. van der Kwast, H. D. de Koning, 2009, The New England journal of medicine.

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

H. D. de Koning, K. Nackaerts, C. Weenink, 2014, The Lancet. Oncology.

Prostate-cancer mortality at 11 years of follow-up.

B. G. Blijenberg, T. H. van der Kwast, H. D. de Koning, 2012, The New England journal of medicine.

Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

H. D. de Koning, K. Nackaerts, C. Weenink, 2013, American journal of respiratory and critical care medicine.

Management of lung nodules detected by volume CT scanning.

Harry J de Koning, Mathias Prokop, Matthijs Oudkerk, 2009, The New England journal of medicine.

Internet-administered adolescent health questionnaires compared with a paper version in a randomized study.

H. D. de Koning, J. van der Lei, H. Raat, 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Internet versus paper mode of health and health behavior questionnaires in elementary schools: asthma and fruit as examples.

Harry J de Koning, H. D. de Koning, H. Raat, 2006, The Journal of school health.

Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation

B. van Ginneken, H. D. de Koning, J. Lammers, 2015, European Respiratory Journal.

First experiences in screening women at high risk for breast cancer with MR imaging

Matthijs Oudkerk, Harry J. de Koning, H. D. de Koning, 2000, Breast Cancer Research and Treatment.

Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

Harry J de Koning, Anssi Auvinen, John K Gohagan, 2002, International journal of cancer.

Lung cancer screening: latest developments and unanswered questions.

H. D. de Koning, C. van der Aalst, K. ten Haaf, 2016, The Lancet. Respiratory medicine.

Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.

Ying Wang, Harry J de Koning, Mathias Prokop, 2009, Radiology.

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Harry J de Koning, Rozemarijn Vliegenthart, Matthijs Oudkerk, 2014, The Lancet. Oncology.

Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.

Harry J de Koning, Bram van Ginneken, Mathias Prokop, 2011, JAMA.

Computer-aided detection versus independent double reading of masses on mammograms.

Nico Karssemeijer, Harry J de Koning, Roland Holland, 2003, Radiology.

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.

Harry J de Koning, Madeleine M A Tilanus-Linthorst, Ellen Warner, 2017, European journal of cancer.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

H. D. de Koning, E. Heijnsdijk, C. Seynaeve, 2012, BMC Cancer.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Harry J de Koning, Madeleine M A Tilanus-Linthorst, Mieke Kriege, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.

Nico Karssemeijer, Harry J de Koning, Ritse M Mann, 2015, Radiology.

Screening for scoliosis: do we have indications for effectiveness?

H. D. de Koning, E. Bunge, R. Juttmann, 2006, Journal of medical screening.

Estimating the Effectiveness of Screening for Scoliosis: In Reply

H. D. de Koning, E. Bunge, 2008, Pediatrics.

Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

V. Wong, H. D. de Koning, F. Lammert, 2021, Hepatology.

Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?

H. D. de Koning, F. Schröder, S. Otto, 2010, European journal of cancer.

European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studies

H. D. de Koning, F. Schröder, L. Denis, 1995, Cancer.

A Cluster-Randomized Trial of Screening for Language Delay in Toddlers: Effects on School Performance and Language Development at Age 8

H. D. de Koning, L. Verhoeven, H. V. van Agt, 2007, Pediatrics.

PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.

H. D. de Koning, A. Villers, S. Moss, 2010, European journal of cancer.

The influence of health systems on breast, cervical and colorectal cancer screening: an overview of systematic reviews using health systems and implementation research frameworks

Eleanor R Turnbull, H. D. de Koning, M. Mckee, 2019, Journal of health services research & policy.

Side‐effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?

J. Habbema, H. D. de Koning, M. Essink‐bot, 2007, BJU international.

Nationwide breast cancer screening programme fully implemented in The Netherlands.

H. D. de Koning, J. Hendriks, P. J. van der Maas, 2001, Breast.

How Does Early Detection by Screening Affect Disease Progression?

Gerrit Draisma, H. D. de Koning, E. Heijnsdijk, 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

Screening for prostate cancer in the US? Reduce the harms and keep the benefit

H. D. de Koning, E. Heijnsdijk, T. D. de Carvalho, 2015, International journal of cancer.

Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST).

H. D. de Koning, M. Mckee, I. D. de Kok, 2018, Health policy.

Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model

H. D. de Koning, J. Mar, A. Arrospide, 2017, BMC Public Health.

The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands

H. D. de Koning, A. Zauber, M. van Ballegooijen, 2015, Gut.

The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial.

H. D. de Koning, R. V. van Klaveren, C. van der Aalst, 2012, Lung cancer.

European position statement on lung cancer screening.

Witold Rzyman, Eugenio Paci, Mario Mascalchi, 2017, The Lancet. Oncology.

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies

Summer S. Han, E. Feuer, S. Plevritis, 2019, Journal of the National Cancer Institute.

Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening

H. D. de Koning, C. van der Aalst, K. ten Haaf, 2018, Thorax.

Cost‐effectiveness of High‐performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening

H. D. de Koning, G. Meijer, M. van Ballegooijen, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results

H. D. de Koning, I. Lansdorp-Vogelaar, A. Gini, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

H. D. de Koning, J. Mar, A. Arrospide, 2018, BMC Cancer.

Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis

E. Kuipers, H. D. de Koning, I. Lansdorp-Vogelaar, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Determining the cause of death in randomized screening trial(s) for prostate cancer

J. Coebergh, H. D. de Koning, S. Ciatto, 2003, BJU International.

[Efficacy of mass screening for breast cancer; reduced mortality nationally and internationally].

H. D. de Koning, J. Hendriks, P. J. van der Maas, 1990, Nederlands tijdschrift voor geneeskunde.

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Oguzhan Alagoz, Karla Kerlikowske, Harry J de Koning, 2016, Annals of internal medicine.

Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia

Jeroen J. van den Broek, H. D. de Koning, E. Heijnsdijk, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

PSA screening for prostate cancer: the current controversy.

H. D. de Koning, F. Schröder, F. Schröder, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

Eveline A M Heijnsdijk, Harry J de Koning, Lurdes Y T Inoue, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening

Karla Kerlikowske, Jane Lange, Diana Miglioretti, 2016, Annals of Internal Medicine.

A cluster-randomised trial of screening for language disorders in toddlers

H. D. de Koning, I. Korfage, J. Polder, 2004, Journal of medical screening.

How cost-effective is breast cancer screening in different EC countries?

H. D. de Koning, P. J. van der Maas, G. V. Van Oortmarssen, 1993, European journal of cancer.

Anticipating the Consequences for the Primary Therapy of Breast Cancer after Introducing Screening: A More Global Picture for Health Care Policy Making

J. Borrás, H. D. de Koning, J. Espinàs, 1998, International Journal of Technology Assessment in Health Care.

Lung cancer screening and smoking cessation efforts

H. D. de Koning, C. van der Aalst, D. Moldovanu, 2021, Translational lung cancer research.

Effects of Systematic Screening and Detection of Child Abuse in Emergency Departments

H. D. de Koning, I. Korfage, H. Moll, 2012, Pediatrics.

Facilitators and barriers to screening for child abuse in the emergency department

H. D. de Koning, I. Korfage, H. Moll, 2012, BMC Pediatrics.

Semi-Automatic Quantification of Subsolid Pulmonary Nodules: Comparison with Manual Measurements

B. van Ginneken, H. Gietema, H. D. de Koning, 2013, PloS one.

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.

Summer S. Han, E. Feuer, S. Plevritis, 2021, JAMA oncology.

Raising the Bar for the U.S. Preventive Services Task Force

S. Plevritis, H. D. de Koning, R. Meza, 2014, Annals of Internal Medicine.

Uniform and blinded cause of death verification of the NELSON lung cancer screening participants.

H. D. de Koning, J. Aerts, M. D. den Bakker, 2017, Lung cancer.

Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?

B. van Ginneken, H. Gietema, H. D. de Koning, 2014, European Respiratory Journal.

Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

William Hazelton, Jihyoun Jeon, Rafael Meza, 2014, Annals of Internal Medicine.

Re: Think before you leap

Summer S. Han, E. Feuer, S. Plevritis, 2018, International journal of cancer.

Prostate cancer diagnosis: the impact on patients' mental health.

H. D. de Koning, M. Essink‐bot, I. Korfage, 2006, European journal of cancer.

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

H. D. de Koning, E. Heijnsdijk, M. Roobol, 2009, British Journal of Cancer.

Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.

H. D. de Koning, F. Schröder, P. J. van der Maas, 2000, The Journal of urology.

Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer

H. D. de Koning, K. Haaf, E. Blom, 2020, PharmacoEconomics.

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies

H. D. de Koning, E. Heijnsdijk, N. V. van Ravesteyn, 2022, International journal of cancer.

Editorial: Social Inequality in Cancer Screening

H. D. de Koning, H. Zeeb, G. V. Van Hal, 2022, Frontiers in Public Health.

The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.

H. D. de Koning, I. D. de Kok, U. Ivanuš, 2020, Gynecologic oncology.

Contribution of CT Quantified Emphysema, Air Trapping and Airway Wall Thickness on Pulmonary Function in Male Smokers With and Without COPD

B. Ginneken, H. D. de Koning, J. Lammers, 2014, COPD.

Computed Tomography Structural Lung Changes in Discordant Airflow Limitation

B. van Ginneken, H. D. de Koning, J. Lammers, 2013, PloS one.

High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction.

P. V. van Ooijen, H. D. de Koning, M. Oudkerk, 2018, Journal of cardiovascular computed tomography.

Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD.

B. van Ginneken, H. Gietema, H. D. de Koning, 2014, Respiratory medicine.

Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening

Harry J de Koning, Bram van Ginneken, Mathias Prokop, 2013, Respiratory Research.

Quantification of coronary artery calcium in nongated CT to predict cardiovascular events in male lung cancer screening participants: results of the NELSON study.

Tim Leiner, Harry J de Koning, Rozemarijn Vliegenthart, 2015, Journal of cardiovascular computed tomography.

Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance

H. D. de Koning, E. Heijnsdijk, T. D. de Carvalho, 2018, Cancer.

The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index.

H. D. de Koning, E. Heijnsdijk, D. Denham, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

H. D. de Koning, I. Korfage, F. Schröder, 2003, International journal of cancer.

Diffuse Idiopathic Skeletal Hyperostosis Is Associated with Lower Lung Volumes in Current and Former Smokers.

H. D. de Koning, J. Lammers, R. Vliegenthart, 2016, American journal of respiratory and critical care medicine.

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)

H. D. de Koning, M. Prokop, R. V. van Klaveren, 2009, British Journal of Cancer.

Lung cancer screening by spiral CT. What is the optimal target population for screening trials?

H. D. de Koning, R. V. van Klaveren, F. Hirsch, 2002, Lung cancer.

No benefit for consensus double reading at baseline screening for lung cancer with the use of semiautomated volumetry software.

H. D. de Koning, R. Vernhout, M. Oudkerk, 2012, Radiology.

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Oguzhan Alagoz, Eveline A M Heijnsdijk, Harry J de Koning, 2014, Journal of the National Cancer Institute.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Oguzhan Alagoz, Rebecca A Hubbard, Karla Kerlikowske, 2014, Journal of the National Cancer Institute.

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs

Jeroen J. van den Broek, H. D. de Koning, N. V. van Ravesteyn, 2022, Cancers.

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Harry J de Koning, Ewout W Steyerberg, Jihyoun Jeon, 2017, PLoS medicine.

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Summer S. Han, E. Feuer, S. Plevritis, 2020, PLoS medicine.

[Screening for lung cancer in the Netherlands: the role of spiral CT scan].

J. Habbema, H. D. de Koning, M. Oudkerk, 2001, Nederlands tijdschrift voor geneeskunde.

How to deal with incidentally detected pulmonary nodules less than 10mm in size on CT in a healthy person.

Harry J de Koning, H. D. de Koning, R. V. van Klaveren, 2008, Lung cancer.

Patients' Preferences for Scoliosis Brace Treatment: A Discrete Choice Experiment

Harry J de Koning, Esther W de Bekker-Grob, H. D. de Koning, 2010, Spine.

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Harry J de Koning, Gerrit Draisma, H. D. de Koning, 2008, Journal of the National Cancer Institute.

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

Harry J de Koning, Edwin K Silverman, Matthijs Oudkerk, 2017, Nature Genetics.

The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening.

Harry J de Koning, H. D. de Koning, E. Heijnsdijk, 2019, Public health research & practice.

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

H. D. de Koning, E. Heijnsdijk, M. Roobol, 2020, Cancer medicine.

Clinical Guidelines Annals of Internal Medicine Effects of Mammography Screening Under Different Screening

Marvin Zelen, Harry J de Koning, Eric J Feuer, 2022 .

Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial.

P. V. van Diest, N. Karssemeijer, H. D. de Koning, 2021, Radiology.

Breast cancer screening halves the risk of breast cancer death: a case-referent study.

Harry J de Koning, Roland Holland, Mechli Imhof-Tas, 2014, Breast.

Mammography Screening and Breast Cancer Mortality—Response

J. Otten, H. D. de Koning, A. Verbeek, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.

Eveline A M Heijnsdijk, Harry J de Koning, Gerard J den Heeten, 2013, European journal of cancer.

[Effects of the population screening into breast cancer].

J. Otten, H. D. de Koning, A. Verbeek, 2013, Nederlands tijdschrift voor geneeskunde.

Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study.

H. D. de Koning, T. Hak, M. Essink‐bot, 2006, Social science & medicine.

Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years.

B. G. Blijenberg, T. H. van der Kwast, H. D. de Koning, 2005, Journal of the National Cancer Institute.

Measuring disease specific quality of life in localized prostate cancer: The Dutch experience

H. D. de Koning, M. Essink‐bot, I. Korfage, 2003, Quality of Life Research.

Estimating the Effectiveness of Screening for Scoliosis: A Case-Control Study

Harry J de Koning, H. D. de Koning, P. A. Wiegersma, 2008, Pediatrics.

Independent double reading of screening mammograms in The Netherlands: effect of arbitration following reader disagreements.

Harry J de Koning, H. D. de Koning, J. Hendriks, 2004, Radiology.

Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators

Tiago M de Carvalho, Eveline A M Heijnsdijk, Luc Coffeng, 2019, Medical decision making : an international journal of the Society for Medical Decision Making.

The MISCAN-Fadia continuous tumor growth model for breast cancer.

Harry J de Koning, J. Habbema, H. D. de Koning, 2006, Journal of the National Cancer Institute. Monographs.

Scientific Advances in Lung Cancer 2015

Kenneth E. Rosenzweig, Hisao Asamura, Annette McWilliams, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Rotterdam AMblyopia screening effectiveness study: detection and causes of amblyopia in a large birth cohort.

H. D. de Koning, H. Simonsz, J. Groenewoud, 2010, Investigative ophthalmology & visual science.

Lung cancer screening by low-dose spiral computed tomography.

M Oudkerk, H. D. de Koning, M. Oudkerk, 2001, The European respiratory journal.

The impact of a lung cancer computed tomography screening result on smoking abstinence

H. D. de Koning, R. V. van Klaveren, C. van der Aalst, 2010, European Respiratory Journal.

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

H. D. de Koning, T. Tammela, A. Auvinen, 2009, Cancer Epidemiology Biomarkers & Prevention.

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000

E. Feuer, H. D. de Koning, T. Holford, 2012, Journal of the National Cancer Institute.

European randomized lung cancer screening trials: Post NLST

H. D. de Koning, M. Oudkerk, R. V. van Klaveren, 2013, Journal of surgical oncology.

Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?

H. D. de Koning, M. Oudkerk, R. Vliegenthart, 2022, Journal of clinical medicine.

Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial

H. D. de Koning, R. V. van Klaveren, M. Essink‐bot, 2010, European Respiratory Journal.

High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer.

H. D. de Koning, R. V. van Klaveren, M. Essink‐bot, 2008, Lung cancer.

Have Preferences of Girls Changed Almost 3 Years after the Much Debated Start of the HPV Vaccination Program in the Netherlands? A Discrete Choice Experiment

H. D. de Koning, I. Korfage, M. van Ballegooijen, 2014, PloS one.

Advanced prostate cancer: Course, care, and cost implications

H. D. de Koning, F. Schröder, P. J. van der Maas, 1999, The Prostate.

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

H. D. de Koning, F. Schröder, R. Boer, 2002, International journal of cancer.

Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?

H. D. de Koning, F. Schröder, S. Otto, 2004, Journal of medical screening.

Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review

Eugenio Paci, Stephen W Duffy, Marco Zappa, 2012, Journal of medical screening.

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study

H. D. de Koning, S. D. de Vlas, M. van Ballegooijen, 2018, PloS one.

E. Kuipers, H. D. de Koning, I. Nagtegaal, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling.

H. D. de Koning, M. van Ballegooijen, I. Lansdorp-Vogelaar, 2015, Gastroenterology.

Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen‐detection in older (65+) men

H. D. de Koning, E. Heijnsdijk, T. D. de Carvalho, 2016, International journal of cancer.

Incidence of Interval Colorectal Cancer After Negative Results From First-round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.

E. Kuipers, H. D. de Koning, I. Nagtegaal, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.

E. Kuipers, H. D. de Koning, M. van Ballegooijen, 2019, Clinical chemistry.

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.

E. Kuipers, H. D. de Koning, I. Nagtegaal, 2017, Gastroenterology.

European randomized study of screening for prostate cancer—The Rotterdam pilot studies

B. G. Blijenberg, H. D. de Koning, F. Schröder, 1996, International journal of cancer.

Foreword: meeting the challenge of prostate cancer.

J. Coebergh, H. D. de Koning, A. Auvinen, 2010, European journal of cancer.

Screening for cancers with a good prognosis: The case of testicular germ cell cancer

H. D. de Koning, E. Heijnsdijk, L. Looijenga, 2021, Cancer medicine.

Improved Harm/Benefit Ratio and Cost-effectiveness of Prostate Cancer Screening Using New Technologies.

H. D. de Koning, E. Heijnsdijk, 2022, European urology.

Which Strategies Reduce Breast Cancer Mortality Most?

A. Jemal, H. D. de Koning, J. Mandelblatt, 2013, Cancer.

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.

H. D. de Koning, T. Tammela, A. Auvinen, 2015, European urology.

Racial Disparities in Breast Cancer Mortality—Response

H. D. de Koning, M. Stoto, E. Heijnsdijk, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

E. Feuer, H. D. de Koning, Ruth Etzioni, 2017, Annals of Internal Medicine.

Costs and effects of ultrasonography in the evaluation of palpable breast masses

H. D. de Koning, J. V. van Engelshoven, G. Beets, 2004, International Journal of Technology Assessment in Health Care.

Breast cancer screening: Evidence for false reassurance?

H. D. de Koning, G. Draisma, M. Tilanus-Linthorst, 2008, International journal of cancer.

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

H. D. de Koning, D. Miglioretti, K. Kerlikowske, 2012, Annals of Internal Medicine.

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial

H. D. de Koning, K. Nackaerts, C. Weenink, 2013, European Respiratory Journal.

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening

H. D. de Koning, E. Heijnsdijk, G. Draisma, 2011, Epidemiologic reviews.

Quality-of-life effects of prostate-specific antigen screening.

H. D. de Koning, T. Tammela, A. Auvinen, 2012, The New England journal of medicine.

The cost-effectiveness of different visual acuity screening strategies in three European countries: A microsimulation study

H. D. de Koning, H. Simonsz, E. Heijnsdijk, 2022, Preventive medicine reports.

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model

H. D. de Koning, E. Heijnsdijk, A. Getaneh, 2021, Cancer medicine.

When should active surveillance for prostate cancer stop if no progression is detected?

H. D. de Koning, E. Heijnsdijk, T. D. de Carvalho, 2017, The Prostate.

The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers.

H. D. de Koning, A. Auvinen, J. Adolfsson, 2019, European urology.

Overdiagnosis in lung cancer screening: why modelling is essential

H. D. de Koning, K. ten Haaf, 2015, Journal of Epidemiology & Community Health.

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

H. D. de Koning, E. Heijnsdijk, J. Hugosson, 2012, British Journal of Cancer.

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

H. D. de Koning, K. ten Haaf, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Gleason score, age and screening: Modeling dedifferentiation in prostate cancer

H. D. de Koning, F. Schröder, G. Draisma, 2006, International journal of cancer.

Five‐year follow‐up of health‐related quality of life after primary treatment of localized prostate cancer

J. Habbema, H. D. de Koning, M. Essink‐bot, 2005, International journal of cancer.

Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age

Oguzhan Alagoz, Natasha K. Stout, Elizabeth S. Burnside, 2017, MDM policy & practice.

The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe

H. D. de Koning, E. Heijnsdijk, I. Lansdorp-Vogelaar, 2021, Preventive medicine reports.

Determinants and outcome of unsuccessful referral after positive screening in a large birth-cohort study of population-based vision screening.

H. D. de Koning, J. Passchier, S. Loudon, 2011, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, F. Lammert, T. Karlsen, 2022, BMC Public Health.

Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries.

Eleanor R Turnbull, H. D. de Koning, M. Mckee, 2018, Health policy.

Disability-Adjusted Life Years Averted Versus Quality-Adjusted Life Years Gained: A Model Analysis for Breast Cancer Screening.

H. D. de Koning, E. Heijnsdijk, I. Lansdorp-Vogelaar, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].

H. D. de Koning, C. V. van Asperen, G. D. de Bock, 2001, Nederlands tijdschrift voor geneeskunde.

Deep Learning for Automatic Calcium Scoring in Population-Based Cardiovascular Screening.

H. D. de Koning, M. Oudkerk, D. Kuijpers, 2021, JACC. Cardiovascular imaging.

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue

H. D. de Koning, E. Heijnsdijk, R. Mann, 2021, Journal of the National Cancer Institute.

Evaluation of Systematic Assessment of Asthma-Like Symptoms and Tobacco Smoke Exposure in Early Childhood by Well-Child Professionals: A Randomised Trial

A. Hofman, H. D. de Koning, L. Duijts, 2014, PloS one.

Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study

H. D. de Koning, I. Lansdorp-Vogelaar, A. Anttila, 2022, Preventive medicine reports.

A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer.

H. D. de Koning, R. Boer, P. Warmerdam, 1997, The Journal of urology.

Response to the letter commenting on 'Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review'.

H. D. de Koning, M. Mckee, I. D. de Kok, 2020, European journal of cancer.

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening

H. D. de Koning, G. D. den Heeten, E. Heijnsdijk, 2016, Breast Cancer Research.

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”

H. D. de Koning, E. Heijnsdijk, N. V. van Ravesteyn, 2022, International journal of cancer.

Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands

H. D. de Koning, E. Heijnsdijk, N. V. van Ravesteyn, 2022, European Journal of Cancer.

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study

H. D. de Koning, I. D. de Kok, J. Hontelez, 2022, BMC Medicine.

Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study

D. Postma, B. van Ginneken, H. D. de Koning, 2013, Respiratory Research.

Cost-effectiveness of colorectal cancer screening in Slovakia

H. D. de Koning, I. Lansdorp-Vogelaar, M. Reckova, 2021, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Accuracy of a screening instrument to identify potential child abuse in emergency departments.

H. D. de Koning, I. Korfage, H. Moll, 2014, Child abuse & neglect.

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Angela Mariotto, Ruth Etzioni, Eric Feuer, 2009, Journal of the National Cancer Institute.

Informed decision‐making about the fetal anomaly scan: what knowledge is relevant?

H. D. de Koning, E. Steegers, M. Essink-Bot, 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Ethnic differences in participation in prenatal screening for Down syndrome: A register‐based study

H. D. de Koning, J. Laudy, M. Essink‐bot, 2010, Prenatal diagnosis.

Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis.

H. D. de Koning, R. Pijnappel, M. Joore, 2020, Radiology.

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges

H. D. de Koning, R. Kaaks, C. van der Aalst, 2021, International journal of cancer.

Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.

H. D. de Koning, E. Heijnsdijk, A. Ponti, 2020, European journal of cancer.

Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.

H. D. de Koning, I. Lansdorp-Vogelaar, R. Meester, 2020, European journal of cancer.

A choice experiment to identify the most important elements of a successful cancer screening program according to those who research and manage such programs

H. D. de Koning, M. Mckee, J. Priaulx, 2018, The International journal of health planning and management.

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

Oguzhan Alagoz, Karla Kerlikowske, Xuelin Huang, 2016, Annals of Internal Medicine.

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Harry J de Koning, Anssi Auvinen, Jack Cuzick, 2009, European urology.

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Harry J de Koning, Gerrit Draisma, H. D. de Koning, 2003, Journal of the National Cancer Institute.

Predictive value of pulsed Doppler echocardiography in acute myocardial infarction.

A. J. Dunning, H. D. de Koning, C. Visser, 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

P. V. van Ooijen, H. D. de Koning, H. Groen, 2016, The Lancet. Oncology.

Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening

H. D. de Koning, J. Groenewoud, H. Koning, 2004, British Journal of Cancer.

Lead-time in the European Randomised Study of Screening for Prostate Cancer.

H. D. de Koning, A. Auvinen, S. Ciatto, 2010, European journal of cancer.

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.

James M. Hodge, Jack A. Taylor, E. Burnside, 2022, JAMA oncology.

Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

H. D. de Koning, M. Oudkerk, C. Henschke, 2020, Cancers.

Psychological distress in women at increased risk for breast cancer: the role of risk perception.

H. D. de Koning, M. Essink‐bot, C. Seynaeve, 2004, European journal of cancer.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2018, Thorax.

Modeling Strategies to Optimize Cancer Screening in USPTSF Guideline-Noncompliant Women.

H. D. de Koning, I. Lansdorp-Vogelaar, I. D. de Kok, 2021, JAMA oncology.

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening

E. Kuipers, H. D. de Koning, I. Nagtegaal, 2019, International journal of cancer.

EU Policy on Lung Cancer CT Screening 2017

H. D. de Koning, M. Oudkerk, E. Paci, 2017, Biomedicine Hub.

Mammography Screening and Risk of Breast Cancer Death: A Population-Based Case–Control Study

J. Otten, H. D. de Koning, A. Verbeek, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.

E W Steyerberg, M W Kattan, T. H. van der Kwast, 2006, The Journal of urology.

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.

T. H. van der Kwast, H. D. de Koning, T. Tammela, 2019, European urology.

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Harry J de Koning, Mathias Prokop, Rozemarijn Vliegenthart, 2020, The New England journal of medicine.

Pathologic features of prostate cancer found at population-based screening with a four-year interval.

T. H. van der Kwast, H. D. de Koning, M. Roobol, 2001, Journal of the National Cancer Institute.

The Role of the (18)F-Fluorodeoxyglucose-Positron Emission Tomography Scan in the Nederlands Leuvens Longkanker Screenings Onderzoek Lung Cancer Screening Trial

H. D. de Koning, R. Vernhout, K. Nackaerts, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years

H. D. de Koning, H. Groen, P. Snijders, 2016, Journal of Clinical Pathology.

Detection of child abuse in emergency departments: a multi-centre study

H. D. de Koning, I. Korfage, H. Moll, 2011, Archives of Disease in Childhood.

Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study

H. D. de Koning, O. Alagoz, M. Ergun, 2019, Journal of General Internal Medicine.

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

H. D. de Koning, E. Heijnsdijk, M. Hooning, 2015, International journal of cancer.

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History

Jeroen J. van den Broek, H. D. de Koning, D. Easton, 2020, Journal of the National Cancer Institute.

Decreased rates of advanced breast cancer due to mammography screening in The Netherlands

H. D. de Koning, A. Verbeek, J. V. van Dijck, 2004, British Journal of Cancer.

Psychological Distress and Breast Self-Examination Frequency in Women at Increased Risk for Hereditary or Familial Breast Cancer

H. D. de Koning, M. Essink‐bot, C. Seynaeve, 2004, Public Health Genomics.

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.

N. Karssemeijer, H. D. de Koning, R. Tollenaar, 2019, The Lancet. Oncology.

Growth of hepatocellular adenoma during pregnancy: a prospective study.

H. D. de Koning, E. Steegers, M. Thomeer, 2020, Journal of hepatology.

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.

H. D. de Koning, E. Heijnsdijk, I. Obdeijn, 2016, European journal of cancer.

Treatment capacity required for full‐scale implementation of lung cancer screening in the United States

H. D. de Koning, D. Arenberg, K. ten Haaf, 2019, Cancer.

Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD

Toshiko Tanaka, L. Ferrucci, D. Postma, 2012, Human Genetics.

A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries.

Eleanor R Turnbull, H. D. de Koning, M. Mckee, 2018, Health policy.

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

H. D. de Koning, T. Tammela, A. Auvinen, 2013, Journal of medical screening.

Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program.

Harry J de Koning, Mathias Prokop, Matthijs Oudkerk, 2008, Radiology.

Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?

H. D. de Koning, M. Essink‐bot, E. Steegers, 2011, Patient Education and Counseling.

Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial)

Harry J de Koning, Mathias Prokop, H. D. de Koning, 2008, Cancer.

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

B. G. Blijenberg, H. D. de Koning, M. Roobol, 2013, European urology.

Reply to Koleva-Kolarova et al.

H. D. de Koning, O. Alagoz, C. Schechter, 2016, Breast.

Lung cancer screening CT-based prediction of cardiovascular events.

Harry J de Koning, Mathias Prokop, Max A Viergever, 2013, JACC. Cardiovascular imaging.

Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.

J. Borrás, M. Coleman, H. D. de Koning, 2008, European journal of cancer.

Automated Coronary Artery Calcification Scoring in Non-Gated Chest CT: Agreement and Reliability

Max A. Viergever, Tim Leiner, Matthijs Oudkerk, 2014, PloS one.

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

H. D. de Koning, R. Tollenaar, E. Heijnsdijk, 2013, Journal of the National Cancer Institute.

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.

H. D. de Koning, W. Kirkels, R. Kranse, 1997, British journal of urology.

Prostate cancer detection at low prostate specific antigen.

H. D. de Koning, A. Vis, R. Kranse, 2000, The Journal of urology.

Summary statement on screening for prostate cancer in Europe

J. Borrás, H. Grönberg, M. Eklund, 2018, International journal of cancer.

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study

H. D. de Koning, E. Heijnsdijk, A. M. Getaneh, 2021, Scientific Reports.

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality

H. D. de Koning, E. Heijnsdijk, J. Mandelblatt, 2012, Breast Cancer Research and Treatment.

Is prostate cancer different in black men? Answers from 3 natural history models

H. D. de Koning, Ruth Etzioni, A. Mariotto, 2017, Cancer.

The importance of screening for lung cancer

H. D. de Koning, N. Horeweg, N. Horeweg, 2014, Expert review of respiratory medicine.

Impact of cause of death adjudication on the results of the European prostate cancer screening trial

H. D. de Koning, A. Auvinen, S. Moss, 2016, British Journal of Cancer.

Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.

Stephan Ripke, Max A Viergever, Matthijs Oudkerk, 2013, Atherosclerosis.

School-based Internet-tailored fruit and vegetable education combined with brief counselling increases children's awareness of intake levels

H. D. de Koning, J. van der Lei, H. Raat, 2007, Public Health Nutrition.

The cost‐effectiveness of breast cancer screening

J. Habbema, H. D. de Koning, J. Hendriks, 1989, International journal of cancer.

Informing on prenatal screening for Down syndrome prior to conception. An empirical and ethical perspective

H. D. de Koning, M. Essink‐bot, E. Steegers, 2012, American journal of medical genetics. Part A.

European Code against Cancer, 4th Edition: Cancer screening.

E. Kuipers, H. D. de Koning, P. Dean, 2015, Cancer epidemiology.

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.

D. Schopper, C. de Wolf, H. D. de Koning, 2009, European journal of cancer.

Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.

Nico Karssemeijer, Harry J de Koning, Roland Holland, 2005, Journal of the National Cancer Institute.

Nation‐wide breast cancer screening in The Netherlands: Results of initial and subsequent screening 1990–1995

H. D. de Koning, J. Hendriks, P. J. van der Maas, 1998, International journal of cancer.

Low-dose computed tomography screening for lung cancer: results of the first screening round.

H. D. de Koning, K. Nackaerts, M. Oudkerk, 2013, Journal of Comparative Effectiveness Research.

Informed decision making does not affect health-related quality of life in lung cancer screening (NELSON trial).

H. D. de Koning, R. V. van Klaveren, M. Essink‐bot, 2010, European journal of cancer.

Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis

Min A. Jhun, Dermot F. Reilly, R. Marioni, 2016, Circulation. Cardiovascular genetics.

Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study

E. Kuipers, H. D. de Koning, E. Steyerberg, 2015, Gut.

A model for breast cancer screening

J D Habbema, G J van Oortmarssen, J. Habbema, 1990, Cancer.

Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease.

B. van Ginneken, H. D. de Koning, J. Lammers, 2015, American journal of respiratory and critical care medicine.

Association of Chronic Obstructive Pulmonary Disease and Smoking Status With Bone Density and Vertebral Fractures in Male Lung Cancer Screening Participants

H. D. de Koning, M. Oudkerk, R. Vliegenthart, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Follow-up of CT-derived airway wall thickness: Correcting for changes in inspiration level improves reliability.

B. van Ginneken, H. D. de Koning, J. Lammers, 2016, European journal of radiology.

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.

E. R. van den Heuvel, H. D. de Koning, T. Helbich, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database

H. D. de Koning, D. Arenberg, K. ten Haaf, 2020, BMJ Open Respiratory Research.

Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses.

Y. Bossé, D. Postma, H. Kauczor, 2015, American journal of respiratory and critical care medicine.

Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study

Cleo C. van Diemen, A. Uitterlinden, M. Obeidat, 2011, PloS one.

Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality

H. D. de Koning, G. Draisma, L. V. van de Poll-Franse, 2004, British Journal of Cancer.

Digital mammography screening: weighing reduced mortality against increased overdiagnosis.

H. D. de Koning, A. Verbeek, G. D. den Heeten, 2011, Preventive medicine.

Life expectancy of screen‐detected invasive breast cancer patients compared with women invited to the Nijmegen screening program

J. Otten, H. D. de Koning, G. D. den Heeten, 2010, Cancer.

Advanced breast cancer and its prevention by screening.

H. D. de Koning, J. de Haes, P. J. van der Maas, 1992, British Journal of Cancer.

Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status

H. D. de Koning, R. V. van Klaveren, J. Aerts, 2015, Cancer Immunology Research.

Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients

H. D. de Koning, R. Vernhout, R. V. van Klaveren, 2014, PloS one.

Increased non‐prostate cancer death risk in clinically diagnosed prostate cancer

H. D. de Koning, M. Roobol, Xiaoye Zhu, 2012, BJU international.

The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.

H. D. de Koning, R. Vernhout, K. Nackaerts, 2012, Chest.

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.

Summer S. Han, E. Feuer, S. Plevritis, 2021, JAMA.

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States

S. Plevritis, H. D. de Koning, C. Kong, 2019, Annals of Internal Medicine.

The impact of overdiagnosis on the selection of efficient lung cancer screening strategies

Summer S. Han, E. Feuer, S. Plevritis, 2017, International journal of cancer.

Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling

Summer S. Han, E. Feuer, S. Plevritis, 2014, PloS one.

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy.

H. D. de Koning, E. Heijnsdijk, A. Ponti, 2023, Journal of medical screening.

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women

Jeroen J. van den Broek, H. D. de Koning, D. Miglioretti, 2021, Journal of the National Cancer Institute.

Effect of screening mammography on breast cancer mortality: Quasi‐experimental evidence from rollout of the Dutch population‐based program with 17‐year follow‐up of a cohort

H. D. de Koning, O. O’Donnell, J. Fracheboud, 2019, International journal of cancer.

Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models

D. Berry, E. Feuer, S. Plevritis, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49

Jeroen J. van den Broek, E. Burnside, S. Plevritis, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

The effect of population‐based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow‐up

H. D. de Koning, G. D. den Heeten, E. Heijnsdijk, 2017, International journal of cancer.

Breast cancer incidence trends in Norway and estimates of overdiagnosis

H. D. de Koning, E. Heijnsdijk, S. Hofvind, 2017, Journal of medical screening.

The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer

H. D. de Koning, E. Heijnsdijk, M. van Ballegooijen, 2016, Journal of medical screening.

Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands

H. D. de Koning, A. Verbeek, H. Koning, 2015, International journal of cancer.

The effects of population‐based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy

Gerrit Draisma, H. D. de Koning, E. Heijnsdijk, 2015, International journal of cancer.

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.

H. D. de Koning, E. Heijnsdijk, A. Trentham-Dietz, 2015, Journal of the National Cancer Institute.

Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.

H. D. de Koning, M. Roobol, C. Bangma, 2013, European urology.

Modeling the impact of population screening on breast cancer mortality in the United States.

Marvin Zelen, Harry J de Koning, Eric J Feuer, 2011, Breast.

Impressive time‐related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975‐2006

J. Otten, H. D. de Koning, A. Verbeek, 2008, International Journal of Cancer.

Seventy‐five years is an appropriate upper age limit for population‐based mammography screening

H. D. de Koning, A. Verbeek, G. Draisma, 2006, International journal of cancer.

Mammography benefit in the Canadian National Breast Screening Study‐2: A model evaluation

Teresa To, Gerrit Draisma, T. To, 2004, International Journal of Cancer.

Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors

H. D. de Koning, J. Hendriks, J. de Haes, 1991, International journal of cancer.

The impact of a breast cancer screening programme on quality‐adjusted life‐years

H. D. de Koning, J. de Haes, P. J. van der Maas, 1991, International journal of cancer.

Are Low‐ and Middle‐Income Countries Becoming the Victim of Western Debates About Breast Screening?

H. D. de Koning, 2010, The breast journal.

Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening

Harry J de Koning, Rozemarijn Vliegenthart, Matthijs Oudkerk, 2017, Thorax.

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012

Oguzhan Alagoz, Harry J de Koning, Xuelin Huang, 2018, JAMA.

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

H. D. de Koning, M. Roobol, Xiaoye Zhu, 2011, European urology.

Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review.

H. D. de Koning, M. Mckee, I. D. de Kok, 2020, European journal of cancer.

Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening Participants

H. D. de Koning, M. Oudkerk, R. Vliegenthart, 2013, PloS one.

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial.

H. D. de Koning, M. Oudkerk, D. Kuijpers, 2020, European heart journal cardiovascular Imaging.

Coronary Artery Calcium Imaging in the ROBINSCA Trial: Rationale, Design, and Technical Background.

P. V. van Ooijen, H. D. de Koning, M. Oudkerk, 2018, Academic radiology.

Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.

H. D. de Koning, M. Oudkerk, D. Kuijpers, 2022, American heart journal.

Interpretation and adherence to the updated risk-stratified guideline for colonoscopy surveillance after polypectomy – a nationwide survey

H. D. de Koning, I. Korfage, E. Dekker, 2020, Endoscopy International Open.

Developing a score chart to improve risk stratification of patients with colorectal adenoma

E. Kuipers, H. D. de Koning, E. Steyerberg, 2016, Endoscopy.

Effectiveness of screening for amblyopia and other eye disorders in a prospective birth cohort study

H. D. de Koning, H. Simonsz, J. Groenewoud, 2013, Journal of medical screening.

Early detection and counselling intervention of asthma symptoms in preschool children: study design of a cluster randomised controlled trial

A. Hofman, H. D. de Koning, H. Moll, 2010, BMC public health.

An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants.

H. D. de Koning, S. Loudon, H. Simonsz, 2012, Ophthalmology.

Plusoptix photoscreener use for paediatric vision screening in Flanders and Iran

H. D. de Koning, H. Simonsz, N. Schalij-Delfos, 2019, Acta ophthalmologica.

Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.

Harry J de Koning, Mathias Prokop, Matthijs Oudkerk, 2009, European journal of radiology.

Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland

H. D. de Koning, A. Aro, M. Schreck, 2005, Psychological Medicine.

The prostate cancer conundrum revisited

E. Feuer, H. D. de Koning, Ruth Etzioni, 2012, Cancer.

Pregnancy and liver adenoma management: PALM-study

H. D. de Koning, E. Steyerberg, E. Steegers, 2012, BMC Gastroenterology.

Informed participation in a randomised controlled trial of computed tomography screening for lung cancer

H. D. de Koning, R. V. van Klaveren, M. Essink‐bot, 2009, European Respiratory Journal.

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study

H. D. de Koning, E. Heijnsdijk, A. Anttila, 2019, Cancer medicine.

Blinded and uniform cause of death verification in a lung cancer CT screening trial.

H. D. de Koning, K. Nackaerts, C. Weenink, 2012, Lung cancer.

Disease-specific mortality may underestimate the total effect of prostate cancer screening

H. D. de Koning, M. Roobol, T. Hakulinen, 2010, Journal of medical screening.

Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.

H. D. de Koning, S. Otto, R. Raaijmakers, 2007, European urology.

Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity?

H. D. de Koning, R. V. van Klaveren, C. van der Aalst, 2010, Best practice & research. Clinical gastroenterology.

Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study

H. D. de Koning, M. Essink‐bot, I. Korfage, 2007, Quality of Life Research.

Impact of screening for breast cancer in high-risk women on health-related quality of life

H. D. de Koning, M. Essink‐bot, G. Borsboom, 2004, British Journal of Cancer.

Psychosocial predictors of first attendance for organised mammography screening

H. D. de Koning, H. Koning, A. Aro, 1999, Journal of medical screening.

Short-term effects of population-based screening for prostate cancer on health-related quality of life.

H. D. de Koning, M. Essink‐bot, P. J. van der Maas, 1998, Journal of the National Cancer Institute.

The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population.

H. D. de Koning, M. Essink‐bot, E. Steegers, 2012, Patient education and counseling.

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk

H. D. de Koning, E. Heijnsdijk, I. Obdeijn, 2021, Breast.

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2016, Thorax.

Race-Specific Impact of Natural History, Mammography Screening, and Adjuvant Treatment on Breast Cancer Mortality Rates in the United States

H. D. de Koning, M. Stoto, E. Heijnsdijk, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.

H. D. de Koning, R. Tollenaar, E. Heijnsdijk, 2020, JAMA oncology.

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada

H. D. de Koning, G. Nicholas, S. Bondy, 2017, PLoS medicine.

Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

H. D. de Koning, R. Boer, P. Warmerdam, 1998, Journal of medical screening.

Breast cancer screening: its impact on clinical medicine.

H. D. de Koning, P. J. van der Maas, G. V. Van Oortmarssen, 1990, British journal of cancer.

Should we start population screening for prostate cancer? Randomised trials are still needed

H. D. de Koning, A. Auvinen, A. Miller, 2002, International journal of cancer.

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals

H. D. de Koning, E. Heijnsdijk, G. Draisma, 2011, British Journal of Cancer.

Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round

H. D. de Koning, N. Ascunce, R. Boer, 1997, International journal of cancer.

Is mass screening for breast cancer cost-effective?

J. Coebergh, H. D. de Koning, J. van Dongen, 1996, European Journal of Cancer.

In search of the best upper age limit for breast cancer screening.

G J van Oortmarssen, H. D. de Koning, P. J. van der Maas, 1995, European journal of cancer.

Nation‐wide breast cancer screening in the Netherlands: Support for breast‐cancer mortality reduction

H. D. de Koning, J. Hendriks, P. J. van der Maas, 1995, International journal of cancer.

Prediction of the effects and costs of breast‐cancer screening in Germany

H. D. de Koning, E. Swart, R. Boer, 1994, International journal of cancer.

Calibrating Parameters for Microsimulation Disease Models

Harry J de Koning, Ewout W Steyerberg, Joost van Rosmalen, 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

The potential of breast cancer screening in Europe

H. D. de Koning, M. Mckee, E. Heijnsdijk, 2020, International journal of cancer.

One-off low-dose CT lung cancer screening in China: an appropriate strategy?

H. D. de Koning, 2022, The Lancet. Respiratory medicine.

Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers.

Harry J de Koning, Bram van Ginneken, Mathias Prokop, 2010, Atherosclerosis.

Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches

Jeroen J. van den Broek, E. Burnside, H. D. de Koning, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)

J. Habbema, H. D. de Koning, R. Kranse, 1999, International journal of cancer.

H. D. de Koning, M. Essink‐bot, P. J. van der Maas, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

H. D. de Koning, M. Essink‐bot, W. Kirkels, 2001, The Prostate.

Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts

Oguzhan Alagoz, Karla Kerlikowske, Mucahit Cevik, 2015, Annals of Internal Medicine.

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios

H. D. de Koning, E. Heijnsdijk, C. Senore, 2021, Cancers.

Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

H. D. de Koning, P. J. van der Maas, R. Boer, 1995, Journal of the National Cancer Institute.

Cumulative risks of false positive recall and screen‐detected breast cancer after multiple screening examinations

J. Otten, H. D. de Koning, E. Heijnsdijk, 2023, International journal of cancer.

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer

H. D. de Koning, D. Nieboer, E. Heijnsdijk, 2018, BJU international.

Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.

H. D. de Koning, C. Seynaeve, M. Essink-Bot, 2006, Breast.

Risk stratification in breast cancer screening: Cost‐effectiveness and harm‐benefit ratios for low‐risk and high‐risk women

H. D. de Koning, E. Heijnsdijk, M. Broeders, 2020, International journal of cancer.

Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer.

B. van Ginneken, H. D. de Koning, I. Išgum, 2012, AJR. American journal of roentgenology.

Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program.

H. D. de Koning, E. Heijnsdijk, J. Mandelblatt, 2015, American journal of preventive medicine.

Predictors of HPV vaccination uptake: a longitudinal study among parents.

H. D. de Koning, I. Korfage, M. van Ballegooijen, 2014, Health education research.

Update on screening and early detection of prostate cancer

H. D. de Koning, S. Otto, 2004, Current opinion in urology.

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

Harry J de Koning, T. H. van der Kwast, H. D. de Koning, 2005, The Journal of urology.

Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.

H. D. de Koning, A. Zauber, M. van Ballegooijen, 2015, Gastroenterology.

Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements.

Mathias Prokop, Matthijs Oudkerk, Ying Wang, 2006, Radiology.

Implementation of lung cancer screening: what are the main issues?

H. D. de Koning, C. van der Aalst, K. ten Haaf, 2021, Translational lung cancer research.

Lung Cancer Detectability by Test, Histology, Stage, and Gender: Estimates from the NLST and the PLCO Trials

H. D. de Koning, J. van Rosmalen, K. ten Haaf, 2014, Cancer Epidemiology, Biomarkers & Prevention.

The impact of PLCO control arm contamination on perceived PSA screening efficacy

H. D. de Koning, Ruth Etzioni, Jeffrey Katcher, 2012, Cancer Causes & Control.

Hereditary breast cancer growth rates and its impact on screening policy.

H. D. de Koning, J. Klijn, W. Hop, 2005, European journal of cancer.

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)

C. Boetes, H. D. de Koning, J. Klijn, 2001, Familial Cancer.

Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up

H. D. de Koning, A. Janssens, M. Essink‐bot, 2006, British Journal of Cancer.

Risk Model–Based Lung Cancer Screening

Summer S. Han, E. Feuer, S. Plevritis, 2023, Annals of Internal Medicine.

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.

H. D. de Koning, M. Puhan, T. Frauenfelder, 2018, Lung cancer.

Selection of eligible participants for screening for lung cancer using primary care data

R. Hubbard, S. Duffy, H. D. de Koning, 2021, Thorax.

The impact on socio‐emotional development and quality of life of language impairment in 8‐year‐old children

H. D. de Koning, L. Verhoeven, G. van den Brink, 2011, Developmental medicine and child neurology.

Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial

H. D. de Koning, M. Oudkerk, C. van der Aalst, 2019, European journal of preventive cardiology.

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

R. Warren, H. D. de Koning, J. Klijn, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study

H. D. de Koning, A. Street, R. Boer, 1998, BMJ.

Cost-Effectiveness of Neonatal Hearing Screening Programs: A Micro-Simulation Modeling Analysis

H. D. de Koning, E. Heijnsdijk, A. Goedegebure, 2020, Ear and hearing.

Cost‐effectiveness of digital mammography screening before the age of 50 in The Netherlands

H. D. de Koning, E. Heijnsdijk, J. Fracheboud, 2015, International journal of cancer.

Assessment of nationwide cancer-screening programmes.

H. D. de Koning, 2000, Lancet.

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing

E. Kuipers, H. D. de Koning, E. Dekker, 2022, PloS one.

Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination.

H. D. de Koning, J. Fracheboud, H. V. van Agt, 2012, Patient education and counseling.

Changes in use of breast-conserving therapy in years 1978-2000.

H. D. de Koning, P. J. van der Maas, J. van Dongen, 1994, British journal of cancer.

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

Andrew J Vickers, Emily Vertosick, Hans Lilja, 2014, BMC Medicine.

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening

J. Otten, H. D. de Koning, A. Verbeek, 2018, BMC Cancer.

H. D. de Koning, H. Raat, Resiti T. Mangunkusumo, 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Sexual function with localized prostate cancer: active surveillance vs radical therapy

H. D. de Koning, E. Steyerberg, M. Essink‐bot, 2012, BJU international.

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam

H. D. de Koning, E. Heijnsdijk, M. Roobol, 2010, Journal of the National Cancer Institute.

Informed decision-making based on a leaflet in the context of prostate cancer screening.

H. D. de Koning, I. Korfage, E. Heijnsdijk, 2019, Patient education and counseling.

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe

H. D. de Koning, I. Lansdorp-Vogelaar, N. Segnan, 2021, MDM policy & practice.

A. Miller, H. D. de Koning, M. Essink‐bot, 2001, European journal of cancer.

Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD

Y. Bossé, D. Postma, T. Beaty, 2014, European Respiratory Journal.

Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population

H. D. de Koning, M. Oudkerk, R. Vliegenthart, 2015, The International Journal of Cardiovascular Imaging.

Work at night and breast cancer--report on evidence-based options for preventive actions.

T. Åkerstedt, H. D. de Koning, J. Olsen, 2012, Scandinavian journal of work, environment & health.

Including the quality‐of‐life effects in the evaluation of prostate cancer screening: expert opinions revisited?

H. D. de Koning, M. Essink‐bot, I. Korfage, 2003, BJU international.

The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials

E. Feuer, H. D. de Koning, Ruth Etzioni, 2018, Cancer.

Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths

H. D. de Koning, E. Heijnsdijk, G. Draisma, 2011, British Journal of Cancer.

Risk stratification based on screening history: the NELSON lung cancer screening study

H. D. de Koning, K. Nackaerts, H. Groen, 2017, Thorax.

Breast cancer screening; cost-effective in practice?

H. D. de Koning, 2000, European journal of radiology.

Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer.

H. D. de Koning, J. Klijn, M. Essink‐bot, 2005, European journal of cancer.

Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?

H. D. de Koning, M. Oudkerk, R. V. van Klaveren, 2012, Lung cancer.

Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Ruth Etzioni, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, 2014, Annals of internal medicine.

Bone density loss on computed tomography at 3-year follow-up in current compared to former male smokers.

H. D. de Koning, J. Lammers, M. Oudkerk, 2017, European journal of radiology.

Overdiagnosis and overtreatment of breast cancer: Microsimulation modelling estimates based on observed screen and clinical data

H. D. de Koning, G. Draisma, J. Fracheboud, 2005, Breast Cancer Research.

[The scientific basis for population screening for breast cancer in the Netherlands].

H. D. de Koning, A. Verbeek, P. J. van der Maas, 2002, Nederlandsch tijdschrift voor geneeskunde.

Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.

Harry J de Koning, H. D. de Koning, J. Groenewoud, 2007, Journal of the National Cancer Institute.

Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome.

H. D. de Koning, J. Groenewoud, R. Roumen, 2008, European journal of cancer.

Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology

Jeroen J. van den Broek, S. Plevritis, H. D. de Koning, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy.

J. Habbema, H. D. de Koning, E. Paci, 1995, European journal of cancer.

Implementation of an Educational Cartoon (“the Patchbook”) and Other Compliance-Enhancing Measures by Orthoptists in Occlusion Treatment of Amblyopia

H. D. de Koning, J. Passchier, S. Loudon, 2016, Strabismus.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, T. Karlsen, G. Pera, 2022, BMC Public Health.

Screening for coronary artery calcium in a high-risk population: the ROBINSCA trial.

H. D. de Koning, M. Oudkerk, D. Kuijpers, 2020, European journal of preventive cardiology.

Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study

H. D. de Koning, M. van Ballegooijen, I. D. de Kok, 2020, BJOG : an international journal of obstetrics and gynaecology.

A longer breast carcinoma screening interval for women age older than 65 years?

H. D. de Koning, P. J. van der Maas, R. Boer, 1999, Cancer.

Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, T. Karlsen, G. Pera, 2023, BMC Public Health.

Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial.

H. D. de Koning, C. van der Aalst, 2016, Lung cancer.

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening

H. D. de Koning, G. D. den Heeten, E. Heijnsdijk, 2016, Breast Cancer Research.

Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts.

N. Karssemeijer, H. D. de Koning, R. Mann, 2018, Clinical radiology.

Serum Lipid Levels, Body Mass Index, and Their Role in Coronary Artery Calcification: A Polygenic Analysis

M. Nöthen, M. Viergever, H. D. de Koning, 2015, Circulation: Cardiovascular Genetics.

Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates.

H. D. de Koning, K. ten Haaf, Erik F. Blom, 2019, Lung cancer.

Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands.

H. D. de Koning, P. J. van der Maas, H. V. van Leiden, 1999, Journal of medical screening.

Modeling the natural history of ductal carcinoma in situ based on population data

E. Burnside, H. D. de Koning, D. Weaver, 2020, Breast Cancer Research.

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).

H. D. de Koning, R. Kranse, M. Roobol, 2004, Urology.

A comparison of parent‐reported wheezing or shortness of breath among infants as assessed by questionnaire and physician‐interview: The Generation R study

A. Hofman, H. D. de Koning, H. Moll, 2010, Pediatric pulmonology.

Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.

H. D. de Koning, S. Otto, F. Schröder, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.

H. D. de Koning, D. Arenberg, K. ten Haaf, 2020, Annals of the American Thoracic Society.

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration

H. D. de Koning, I. Lansdorp-Vogelaar, R. Meester, 2021, PloS one.

Screening for type 2 diabetes in a high-risk population: study design and feasibility of a population-based randomized controlled trial

H. D. de Koning, R. Heine, Y. van der Graaf, 2012, BMC Public Health.

Mammographic screening: evidence from randomised controlled trials.

H. D. de Koning, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Bracing Patients with Idiopathic Scoliosis: Design of the Dutch Randomized Controlled Treatment Trial

H. D. de Koning, E. Bunge, 2008, BMC musculoskeletal disorders.

Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age

Jeroen J. van den Broek, E. Burnside, H. D. de Koning, 2017, MDM policy & practice.

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors

H. D. de Koning, E. Heijnsdijk, G. Draisma, 2013, British Journal of Cancer.

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

D. Berry, E. Feuer, S. Plevritis, 2009, Annals of internal medicine.

The impact of a breast cancer screening programme on quality‐adjusted life‐years

Harry J. de Koning, Gerrit J. van Oortmarssen, H. D. de Koning, 1991, International journal of cancer.

Quantification of growth patterns of screen-detected lung cancers: The NELSON study.

H. D. de Koning, K. Nackaerts, C. Weenink, 2017, Lung cancer.

Wise Prostate-specific Antigen Testing Means a Limited, Risk-adjusted, and Personal Approach.

H. D. de Koning, E. Heijnsdijk, 2023, European urology.

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

H. D. de Koning, J. Eastham, A. Auvinen, 2016, Cancer.

Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).

H. D. de Koning, R. V. van Klaveren, S. Otto, 2010, Lung cancer.

Coronary artery calcium scoring in individuals at risk for coronary artery disease: current status and future perspectives.

H. D. de Koning, C. van der Aalst, M. Vonder, 2020, The British journal of radiology.

Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.

J. Coebergh, H. D. de Koning, J. Groenewoud, 2009, European journal of cancer.

Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000–2005

H. D. de Koning, J. Groenewoud, R. Roumen, 2008, European Radiology.

Patients' Preferences for Scoliosis Brace Treatment: A Discrete Choice Experiment

H. D. de Koning, M. Essink‐bot, E. D. de Bekker-Grob, 2010, Spine.

Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer

H. D. de Koning, J. Klijn, R. Tollenaar, 2006, Breast Cancer Research and Treatment.

Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.

H. D. de Koning, M. Essink‐bot, I. Korfage, 2008, Urology.

Screening and prostate-cancer mortality in a randomized European study.

B. G. Blijenberg, H. D. de Koning, T. Tammela, 2009, The New England journal of medicine.

Paracetamol in suicide and non-accidental overdose-are restrictions justified ?

H. D. de Koning, U. Werneke, P. Warmerdam, 2022 .

New Fissure-attached Nodules in Lung Cancer Screening: A Brief Report from The NELSON Study.

H. D. de Koning, K. Nackaerts, H. Groen, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Management of lung nodules detected by volume CT scanning.

P. V. van Ooijen, H. Gietema, H. D. de Koning, 2009, The New England journal of medicine.

Influence of lung nodule margin on volume- and diameter-based reader variability in CT lung cancer screening.

Harry J de Koning, Rozemarijn Vliegenthart, Matthijs Oudkerk, 2018, The British journal of radiology.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2018, Lung cancer.

Reply: stage distribution of lung cancers detected by computed tomography screening in the NELSON Trial.

H. D. de Koning, N. Horeweg, 2013, American journal of respiratory and critical care medicine.

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial

H. D. de Koning, K. Nackaerts, H. Groen, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

H. D. de Koning, J. Eastham, A. Auvinen, 2016, Cancer.

H. D. de Koning, M. Roobol, Xiaoye Zhu, 2011, European urology.

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

E. Feuer, H. D. de Koning, Ruth Etzioni, 2009, Journal of the National Cancer Institute.

Prostate-cancer mortality at 11 years of follow-up.

B. G. Blijenberg, T. H. van der Kwast, H. D. de Koning, 2012, The New England journal of medicine.

Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review

S. Duffy, H. D. de Koning, E. Paci, 2012, Journal of medical screening.

Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?

H. D. de Koning, M. Essink-Bot, H. V. van Agt, 2011, Patient education and counseling.

Serum Lipid Levels, Body Mass Index, and Their Role in Coronary Artery Calcification: A Polygenic Analysis

M. Nöthen, M. Viergever, H. D. de Koning, 2015, Circulation. Cardiovascular genetics.

B. van Ginneken, H. D. de Koning, M. Prokop, 2010, Atherosclerosis.

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.

E. Kuipers, H. D. de Koning, I. Nagtegaal, 2017, Gastroenterology.

Lung-Cancer Screening and the NELSON Trial. Reply.

H. D. de Koning, M. Oudkerk, C. van der Aalst, 2020, The New England journal of medicine.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2018, Lung cancer.

Cost‐effectiveness of digital mammography screening before the age of 50 in The Netherlands

H. D. de Koning, E. Heijnsdijk, J. Fracheboud, 2015, International journal of cancer.

Are Low‐ and Middle‐Income Countries Becoming the Victim of Western Debates About Breast Screening?

H. D. de Koning, 2010, The breast journal.

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.

H. D. de Koning, T. Tammela, A. Auvinen, 2015, European urology.

Lung cancer screening in never-smokers: a balancing act.

H. D. de Koning, M. Callister, 2023, The Lancet. Respiratory medicine.

Mammographic screening: evidence from randomised controlled trials.

H. D. de Koning, H. Koning, H. J. de Koning, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts

J. Otten, H. D. de Koning, A. Verbeek, 2013, British Journal of Cancer.